|
64Cu-GRIP B Clinical Trials
1 actively recruiting trial across 1 location
Also known as: granzyme B, 64-copper granzyme targeting restricted interaction peptide specific to family member B
San Francisco, California1 trial
PET Imaging Study of 64Cu-GRIP B for Patients Receiving CD19-directed CAR-T Therapy
University of California, San Francisco
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.